Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland

Journal of Mammary Gland Biology and Neoplasia

Volumn 2, Issue 2, 1997, Pages 153-163

  Bates, Nicholas P ^a   Hurst, Helen C ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

EGFR; ErbB2; ErbB3; Neu; Transcription

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN TYROSINE KINASE;

ANIMAL; BREAST; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTO ONCOGENE; RAT; REVIEW; UDDER;

ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; MAMMARY GLANDS, ANIMAL; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TRANSCRIPTION, GENETIC;

EID: 0031107225     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026303814855     Document Type: Article

References (79)

1. M. Sibilia and E. F. Wagner (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269:234-238.
2. K.-F. Lee, H. Simon, H. Chen, B. Bates, M. Hung, and C. Hauser (1995). Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378:394-398.
3. M. Gassmann, F. Casagranda, D. Orioli, H. Simon, C. Lai, R. Klein, and G. Lemke (1995). Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378:390-394.
4. G. T. Merlino (1990). Epidermal growth factor receptor regulation and function. Semin. Cancer Biol. 1:277-284.
5. S. A. Chrysogelos and R. B. Dickson (1994). EGF receptor expression, regulation, and function in breast-cancer. Breast. Cancer Res. Treat. 29:29-40.
6. N. E. Davidson, E. P. Gelmann, M. E. Lippman, and R. B. Dickson (1987). Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol. 1:216-223.
7. J. Haley, N. Whittle, P. Bennet, D. Kinchington, A. Ullrich, and M. Waterfield (1987). The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncogene Res. 1:375-396.
8. S. Ishii, Y. H. Xu, R. H. Stratton, B. A. Roe, G. T. Merlino, and I. Pastan (1985). Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 82:4920-4924.
9. R. I. Yarden, A. H. Lauber, D. Elashry, and S. A. Chrysogelos (1996). Bimodal regulation of epidermal growth-factor receptor by estrogen in breast-cancer cells. Endocrinology 137:2739-2747,
10. A. C. Johnson (1996). Activation of epidermal growth-factor receptor gene-transcription by phorbol 12-myristate 13-acetate is mediated by activator protein-2. J. Biol. Chem. 271:3033-3038.
11. L. G. Hudson, K. L. Thompson, J. Xu, and G. N. Gill (1990). Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 87:7536-7540.
12. J. Xu, K. L. Thompson, L. B. Shephard, L. G. Hudson, and G. N. Gill (1993). T(3) receptor suppression of sp1-dependent transcription from the epidermal growth-factor receptor promoter via overlapping DNA-binding sites J. Biol. Chem. 268:16065-16073.
13. J. A. Fernandez Pol, P. D. Hamilton, and D. J. Klos (1989). Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor beta 1, and triiodothyronine in MDA-468 cells. J. Biol. Chem. 264:4151-4156.
14. D. Gross and W. Garrard (1988). Nuclease hypersensitive sites in chromatin. Ann. Rev. Biochem. 57:159-197.
15. S. A. Chrysogelos. (1993). Chromatin structure of the EGFR gene suggests a role for intron-1 sequences in its regulation in breast-cancer cells. Nucleic Acids Res. 21:5736-5741.
16. J. D. Haley and M. D. Waterfield (1991). Contributory effects of de Novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis. J. Biol. Chem. 266:1746-1753.
17. T. Maekawa, F. Imamoto, G. T. Merlino, I. Pastan, and S. Ishii (1989). Cooperative function of two separate enhancers of the human epidermal growth factor receptor proto-oncogene. J. Biol. Chem. 264:5488-5494.
18. D. J. Slamon, W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press (1989). Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
19. C. Wright, S. Nicholson, B. Angus, J. Sainsbury, J. Farndon, J. Cairns, A. Harris, and C. Horne (1992). Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Brit. J. Cancer. 65:118-121.
20. H. Muss, A. Thor, D. Berry, T. Kute, E. Liu, F. Koerner, M. Cirrincione, D. Budman, W. Wood, M. Barcos, and I. Henderson (1994). c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. New Engl. J. Med. 330:1260-1266.
21. M. Kraus, N. Popescu, S. Amsbaugh, and C. King (1987). Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO Journal. 6:605-610.
22. S. Miller, T. Suen, T. Sexton, and M. Hung. (1994). Mechanisms of deregulated her2/neu expression in breast-cancer cell-lines. Intl. J. Oncology 4:599-608.
23. D. P. Hollywood and H. C. Hurst (1993). A novel transcription factor, OB2-1, is required for overexpression of the protooncogene c-erbB-2 in mammary tumor lines. EMBO J. 12:2369-2375.
24. F. Pasleau, M. Grooteclaes, and R. Golwinkler (1993). Expression of the c-erbB-2 gene in the BT474 human mammary tumor cell-line-measurement of c-erbB-2 messenger-RNA half-life. Oncogene 8:849-854.
25. S. Ishii, F. Imamoto, Y. Yamanishi, K. Toyoshima, and T. Yamamoto (1987). Characterization of the promoter region of the human c-erbB-2 protooncogene. Proc. Natl. Acad. Sci. U.S.A. 84:4374-4378.
26. M. Tal, C. King, M. Kraus, A. Ullrich, J. Schlessinger, and D. Givol (1987). Human her2 (neu) promoter - evidence for multiple mechanisms for transcriptional initiation. Mol. Cell. Biol. 7:2597-2601.
27. G. Mizuguchi, C. Kaneiishii, T. Sawazaki, M. Horikoshi, R. Roeder, T. Yamamoto, and S. Ishii (1994). Independent control of transcription initiations from 2 sites by an initiator-like element and tata box in the human c-erbB-2 promoter. FEBS Letters. 348:80-88.
28. T. Suen and M. Hung (1990). Multiple cis-acting and transacting elements involved in regulation of the neu gene. Mol. Cell. Biol. 10:6306-6315.
29. M. White and M. Hung (1992). Cloning and characterization of the mouse neu promoter. Oncogene 7:677-683.
30. L. Hudson, A. Ertl, and G. Gill (1990). Structure and inducible regulation of the human c-erbB-2lneu promoter. J. Biol. Chem. 265:4389-4393.
31. A. Ertl and G. Gill (1993). Structural features of the 5′ region of the human erbB-2 gene. Gene. 136:361-364.
32. G. Scott, J. Daniel, X. Xiong, R. Maki, D. Kabat, and C. Benz (1994). Binding of an ETS-related Protein within the DNase 1 hypersensitive site of the HER2/neu promoter in human breast cancer cells. J. Biol. Chem. 269:19848-19858.
33. J. M. Bosher, T. Williams, and H. C. Hurst (1995). The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. U.S.A. 92:744-747.
34. J. Bosher, N. F. Totty, J. J. Hsuan, T. Williams, and H. C. Hurst (1996). A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13:1701-1707.
35. F. Sarkar, M. Smith, T. Hoover, G. Princler, J. Crissman, D. Visscher, D. Longo, H. Kung, and Raziuddin (1994). c-erbB-2 promoter-specific DNA-binding protein isolated from human breast-cancer tissues displays mitogenic activity. J. Biol. Chem. 269:12285-12289.
36. Y. Chen and G. Gill (1994). Positive and negative regulatory elements in the human erbB-2 promoter. Oncogene 9:2269-2276.
37. Y. Chen and G. Gill (1996). A heterodimeric nuclear-protein complex binds 2 palindromic sequences in the proximal enhancer of the human erbB-2 gene. J. Biol. Chem. 271:5183-5188.
38. M. Guerin, Z.-M. Sheng, N. Andrieu, and G. Riou (1990). Strong association between c-myb and estrogen-receptor expression in human breast cancer. Oncogene 5:131-135.
39. G. Mizuguchi, C. Kaneiishii, T. Takahashi, T. Yasukawa, T. Nagase, M. Horikoshi, T. Yamamoto, and S. Ishii (1995). c-myb repression of c-erbB-2 transcription by direct binding to the c-erbB-2 promoter. J. Biol. Chem. 270:9384-9389.
40. M. Grooteclaes, F. Pasleau, H. Dijkmans, P. Berzi, A. Albert, and R. Winklergol (1994). The 6-kilobase c-erbB-2 promoter contains positive and negative regulatory elements functional in human mammary cell-lines. Cancer Res. 54:4193-4199.
41. D. Taverna, S. Antoniotti, P. Maggiora, C. Dati, M. DeBortoli, and N. Hynes (1994). ErbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents. Int. J. Cancer. 56:522-528.
42. C. Dati, S. Antoniotti, D. Taverna, I. Perroteau, and M. De Bortoli (1990). Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5:1001-1006.
43. K. S. Russell and M.-C. Hung (1992). Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Cancer Res. 52:6624-6629.
44. S. Antoniotti, P. Maggiora, C. Dati, and M. DeBortoli (1992). Tamoxifen up-regulates c-erbB-2 expression in estrogen-responsive breast-cancer cells in vitro. Eur. J. Cancer. 28:318-321.
45. C. Shih, L. C. Padhy, M. Murray, and R. A. Weinberg (1981). Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290:261-264.
46. D. Van and M. Hung (1991). Identification and characterization of a novel enhancer for the rat neu promoter. Mol. Cell. Biol. 11:1875-1882.
47. D. Yan and M. Hung (1993). Differential activity of the rvf enhancer element in the decreased expression of the neu oncogene in nr-6 cells versus parental swiss webster 3T3 cells. Mol. Carcin. 7:44-49.
48. X. Zhao and M. Hung (1992). Negative autoregulation of the neu gene is mediated by a novel enhancer. Mol. Cell. Biol. 12:2739-2748.
49. C. Galang, J. Garciaramirez, P. Solski, J. Westwick, C. Der, N. Neznanov, R. Oshima, and C. Hauser (1996). Oncogenic neu/erbb-2 increases ets, AP-1, and nf-kappa-b-dependent gene-expression, and inhibiting ets activation blocks neu-mediated cellular-transformation. J. Biol. Chem. 271:7992-7998.
50. D. Yu, K. Scorsone, and M. Hung (1991). Adenovirus type-5 ela gene-products act as transformation suppressors of the neu oncogene. Mol. Cell. Biol. 11:1745-1750.
51. D. Yan, L. Chang, and M. Hung (1991). Repressed expression of the her-2/c-erbB-2 protooncogene by the adenovirus ela gene products. Oncogene 6:343-345.
52. D. Yu, T. Suen, D. Yan, L. Chang, and M. Hung (1990). Transcriptional repression of the neu protooncogene by the adenovirus-5 ela gene-products. Proc. Natl. Acad. Sci. U.S.A. 87:4499-4503.
53. A. Matin and M. Hung (1993). Negative regulation of the neu promoter by the SV40 large T-antigen. Cell Growth Differ. 4:1051-1056.
54. T. Suen and M. Hung. (1991). C-myc reverses new-induced transformed morphology by transcriptional repression. Mol. Cell. Biol. 11:354-362.
55. D. Yu, A. Matin, and M. Hung (1992). The retinoblastoma gene-product suppresses neu oncogene-induced transformation via transcriptional repression of neu. J. Biol. Chem. 267:10203-10206.
56. A. Matin and M. Hung. (1994). The retinoblastoma gene-product, Rb, represses neu expression through 2 regions within the neu regulatory sequence. Oncogene 9:1333-1339.
57. A. Matin, Y. Xie, M. Kao, and M. Hung (1995). Rodent p53 suppresses the transforming activity of the activated neu oncogene by modulating the basal promoter activity of neu. Int. J. Oncol. 6:1087-1092.
58. S. Miller and M. Hung (1995). Regulation of her2/neu gene-expression (review). Oncology Reports 2:497-503.
59. S. Noonberg, G. Scott, C. Hunt, M. Hogan, and C. Benz (1994). Inhibition of transcription factor-binding to the her2 promoter by triplex-forming oligodeoxyribonucleotides. Gene. 149: 123-126.
60. J. Gee, R. Yen, M. Hung, and M. Hogan (1994). Triplex formation at the rat neu oncogene promoter. Gene. 149:109-114.
61. D. P. Hollywood and H. C. Hurst (1995). Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma. Br. J. Cancer 71:753-757.
62. J. D. Harris, A. A. Gutierrez, H. C. Hurst, K. Sikora, and N. R. Lemoine (1994). Gene therapy for cancer using tumour-specific prodrug activation. Gene Therapy. 1:1-6.
63. A. Skinner and H. C. Hurst (1993). Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines. Oncogene 8:3393-3401.
64. K. Shiga, C. Shiga, H. Sasano, S. Miyazaki, T. Yamamoto, M. Yamamoto, N. Hayashi, T. Nishihira, and S. Mori (1993). Expression of c-erbB-2 in human esophageal-carcinoma cells-overexpression correlated with gene amplification or with gata-3 transcription factor expression. Anticancer Res. 13:1293-1301.
65. A. C. Johnson, Y. Jinno, and G. T. Merlino (1988). Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nuclease. Mol. Cell. Biol. 8:4174-4184.
66. A. C. Johnson, S. Ishii, Y. Jinno, I. Pastan, and G. T. Merlino (1988). Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites. J. Biol. Chem. 263:5693-5699.
67. R. Kageyama, G. T. Merlino, and I. Pastan (1988). Epidermal growth factor (EGF) receptor gene transcription. Requirement for SpI and an EGF receptor-specific factor. J. Biol. Chem. 263:6329-6336.
68. L. L. Chen, M. L. Clawson, S. Bilgrami, and G. Carmichael (1993). A sequence-specific single-stranded DNA-binding protein that is responsive to epidermal growth-factor recognizes an si nuclease-sensitive region in the epidermal growth-factor receptor promoter. Cell Growth Differ. 4:975-983.
69. R. Kageyama, G. T. Merlino, and I. Pastan (1988). A transcription factor active on the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 85:5016-5020.
70. R. Kageyama, G. T. Merlino, and I. Pastan (1989). Nuclear factor ETF specifically stimulates transcription from promoters without a TATA box. J. Biol. Chem. 264:15508-15514.
71. R. Kageyama and I. Pastan (1989). Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell. 59:815-825.
72. X. Y. Hou, A. C. Johnson, and M. R. Rosner (1994). Identification of an epidermal growth-factor receptor transcriptional repressor. J. Biol. Chem. 269:4307-4312.
73. X. Y. Hou, A. C. Johnson, and M. R. R. Rosner (1994). Induction of epidermal growth-factor receptor gene-transcription by transforming growth-factor-beta-1-association with loss of protein-binding to a negative regulatory element. Cell Growth. Differ. 5:801-809.
74. L. G. Hudson, J. B. Santon, and G. N. Gill (1989). Regulation of epidermal growth factor receptor gene expression. Mol. Endocrinol. 3:400-408.
75. J. D. Bjorge, A. J. Paterson, and J. E. Kudlow (1989). Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line. J. Biol. Chem. 264:4021-4027.
76. L. C. Murphy, L. J. Murphy, and R. P. Shiu (1988). Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells. Biochem. Biophys. Res. Commun. 150:192-196.
77. L. G. Hudson, J. B. Santon, C. K. Glass, and G. N. Gill (1990). Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell. 62:1165-1175.
78. Z. S. Zheng, R. Polakowska, A. Johnson, and L. A. Goldsmith (1992). Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth. Differ. 3:225-232.
79. S. P. Deb, R. M. Munoz, D. R. Brown, M. A. Subler, and S. Deb (1994). Wild-type human p53 activates the human epidermal growth-factor receptor promoter. Oncogene 9:1341-1349.